CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (87,987)	$ 49,904	$ (307,218)
Adjustments to net income (loss):
Depreciation and amortization	633,408	645,292	665,072
Deferred income tax expense (benefit)	21,685	15,881	7,335
Impairments and other charges	26,079	8,318
Amortization of debt discount and deferred financing costs	8,810	8,735	8,138
Losses (gains) on debt buyback	14,857	(25,275)	(4,119)
Losses (gains) on sale of long-lived assets, net	27,927	13,920	7,352
Share-based compensation	16,501	15,839	15,828
Foreign currency transaction losses (gains), net	28,150	37,286	6,689
Mark-to-market (gain) loss on warrants	(16,894)	(54,684)	95,909
Net loss (gain) related to investment in Vast	4,575	(7,167)
Other	5,539	2,427	869
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(42,440)	(27,129)	(54,501)
Inventory	16,099	(19,432)	928
Other current assets	(4,511)	11,644	3,690
Other long-term assets	(6,478)	(1,283)	(11,196)
Trade accounts payable and accrued liabilities	(25,150)	(32,389)	61,636
Income taxes payable	(34,590)	24,135	8,616
Other long-term liabilities	(4,148)	(28,160)	(3,939)
Net cash provided by (used for) operating activities	581,432	637,862	501,089
Cash flows from investing activities:
Purchases of investments	(7,718)	(38,283)	(21,116)
Capital expenditures	(567,919)	(540,851)	(373,445)
Proceeds from sales of assets	15,498	14,133	26,713
Other	4,681	(5,423)	(860)
Net cash (used for) provided by investing activities	(555,458)	(570,424)	(368,708)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	550,000	900,000
Reduction in long-term debt	(1,197,024)	(298,474)	(182,601)
Debt issuance costs	(11,049)	(18,310)	(3,864)
Proceeds from revolving credit facilities	315,000	290,000	335,000
Reduction in revolving credit facilities	(315,000)	(290,000)	(795,000)
Dividends to common and preferred shareholders	(87)	(194)	(65)
Redeemable noncontrolling interest distribution related to Sanad			(10,324)
Distributions to noncontrolling interest	(950)	(2,269)	(3,489)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders		(286,366)
Sale of non-controlling interest - special purpose acquisition company		305,000
Other	(2,940)	(6,795)	(1,189)
Net cash (used for) provided by financing activities	(662,050)	592,592	(661,532)
Effect of exchange rate changes on cash and cash equivalents	(15,146)	(22,988)	(7,219)
Net increase (decrease) in cash and cash equivalents and restricted cash	(651,222)	637,042	(536,370)
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140	1,273,510
Cash and cash equivalents and restricted cash, end of period	722,960	1,374,182	737,140
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	1,057,487	451,025	991,471
Restricted cash, beginning of period	316,695	286,115	282,039
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140	1,273,510
Cash and cash equivalents, end of period	389,652	1,057,487	451,025
Restricted cash, end of period	$ 333,308	$ 316,695	$ 286,115
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 722,960	$ 1,374,182	$ 737,140